DRDR:LSE:LSE-iShares Healthcare Innovation UCITS ETF USD (Acc) (GBX)

ETF | Others |

Last Closing

USD 560.375

Change

0.00 (0.00)%

Market Cap

N/A

Volume

5.36K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-15 )

Largest Industry Peers for Others

ETFs Containing DRDR:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.72% 12% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.72% 12% F 21% F
Trailing 12 Months  
Capital Gain -3.43% 16% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.43% 16% F 30% F
Trailing 5 Years  
Capital Gain -6.51% 19% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.51% 13% F 26% F
Average Annual (5 Year Horizon)  
Capital Gain -3.16% 12% F 25% F
Dividend Return -3.16% 10% F 24% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.05% 56% F 74% C
Risk Adjusted Return -26.23% 12% F 21% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.